---
title: "Hansen Pharmaceutical: Net profit of 220 million yuan in 2024, a year-on-year increase of 7.43%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237569423.md"
description: "Hansen Pharmaceutical announced that the operating revenue for 2024 is expected to be 1.004 billion yuan, a year-on-year increase of 5.12%. The net profit attributable to shareholders of the listed company is 220 million yuan, a year-on-year increase of 7.43%. The basic earnings per share is 0.4377 yuan/share, a year-on-year increase of 7.44%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital by converting reserves into share capital"
datetime: "2025-04-25T11:40:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237569423.md)
  - [en](https://longbridge.com/en/news/237569423.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237569423.md)
generator: "portal-rs"
---

# Hansen Pharmaceutical: Net profit of 220 million yuan in 2024, a year-on-year increase of 7.43%

Hansen Pharmaceutical announced that the operating revenue for 2024 is 1.004 billion yuan, a year-on-year increase of 5.12%. The net profit attributable to shareholders of the listed company is 220 million yuan, a year-on-year increase of 7.43%. The basic earnings per share is 0.4377 yuan/share, a year-on-year increase of 7.44%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

### Related Stocks

- [002412.CN](https://longbridge.com/en/quote/002412.CN.md)

## Related News & Research

- [Helia Group (ASX:HLI) Unveils Buyback And Dividends, Is The Upside Already Priced In?](https://longbridge.com/en/news/296431214.md)
- [US Airports Remain Busy Despite Surging Prices](https://longbridge.com/en/news/296427822.md)
- [VGP FY26 H1 pretax profit rises to €141 million; net rental income climbs 18% to €122.8 million](https://longbridge.com/en/news/296436597.md)
- [23:31 ETWACO Corp. Unveils Redesigned 'ATLAS' Smart Public Water Refill Station Following Successful Tokyo PoC](https://longbridge.com/en/news/296430029.md)
- [Rein Therapeutics releases corporate presentation on LTI-03 idiopathic pulmonary fibrosis program](https://longbridge.com/en/news/296389731.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**